Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)

NCT01082549 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

780

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Cell Lung Cancer

Interventions

DRUG: gemcitabine/carboplatin
DRUG: gemcitabine/carboplatin plus Iniparib

Sponsor

Sanofi